Morningstar

Bio-Techne Corp TECH

Morningstar Rating
Unlock
Stock XNAS Rating as of
$74.78 +0.78 (1.05%)
View Full Chart
As of Delayed Price Post-Trading: $78.30 +3.52

Company Report

View Archive

Price vs Fair Value

View History
TECH is trading at a 816% premium.
Price
$74.00
Fair Value
$65.00
Uncertainty
High
1-Star Price
$375.28
5-Star Price
$14.30
Economic Moat
Bgwlj
Capital Allocation
Qpsnhrbwx

Bulls Say, Bears Say

Bulls

The firm's reputation for excellent proteomic reagents and instruments allow it to generate high profit margins and strong cash flow.

Bears

Bio-Techne's long-term strategy relies on acquisitions, and the company may have difficulty finding suitable targets due to high valuations or scarcity. Additionally, it may fail to successfully integrate and scale up an acquired business.

Show More

News

View All

Trading Information

Previous Close Price
$74.00
Day Range
$74.05–75.74
52-Week Range
$51.79–85.57
Bid/Ask
$73.55 / $75.97
Market Cap
$11.86 Bil
Volume/Avg
703,858 / 893,552

Key Statistics

Price/Earnings (Normalized)
41.57
Price/Sales
10.26
Dividend Yield (Trailing)
0.43%
Dividend Yield (Forward)
0.43%
Total Yield
1.11%

Company Profile

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Mid Core
Total Number of Employees
3,100
Website
https://www.bio-techne.com

Competitors

Valuation

View More
Metric
TECH
BIO
TMO
Price/Earnings (Normalized)
 41.5731.1327.51
Price/Book Value
 5.661.404.84
Price/Sales
 10.263.785.47
Price/Cash Flow
 38.499.8526.95
Price/Earnings
TECH
BIO
TMO

Financial Strength

Metric
TECH
BIO
TMO
Quick Ratio
 2.474.231.24
Current Ratio
 3.876.281.72
Interest Coverage
 12.59−35.804.91
Quick Ratio
TECH
BIO
TMO

Profitability

Metric
TECH
BIO
TMO
Return on Assets (Normalized)
 10.51%2.66%8.68%
Return on Equity (Normalized)
 14.22%3.75%18.42%
Return on Invested Capital (Normalized)
 11.85%2.93%10.79%
Return on Assets
TECH
BIO
TMO

Biotechnology Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Novo Nordisk AS ADR
NVO
XvzfpwxydWqntz$516.0 Bil
 Vertex Pharmaceuticals Inc
VRTX
PscmmqcbmSwpkww$117.1 Bil
 Regeneron Pharmaceuticals Inc
REGN
HykcnrzpnFgcczl$111.8 Bil
 Alnylam Pharmaceuticals Inc
ALNY
TpjhyqtShsccx$34.6 Bil
 argenx SE ADR
ARGX
VrhyvcvqPgg$33.0 Bil
 BioNTech SE ADR
BNTX
LtsqmqvzTph$28.5 Bil
 Moderna Inc
MRNA
KspznddzlGpx$23.5 Bil
 United Therapeutics Corp
UTHR
VbzfpnrgVfq$15.6 Bil
 Biomarin Pharmaceutical Inc
BMRN
XyhtvttpSmtqshf$13.0 Bil
 Incyte Corp
INCY
ZsgjrhvpQpdrgt$12.9 Bil

Sponsor Center